Splicing and neurodegeneration

Insights and mechanisms

Research output: Contribution to journalReview article

Abstract

Splicing is the global cellular process whereby intervening sequences (introns) in precursor messenger RNA (pre-mRNA) are removed and expressed regions (exons) are ligated together, resulting in a mature mRNA transcript that is exported and translated in the cytoplasm. The tightly regulated splicing cycle is also flexible allowing for the inclusion or exclusion of some sequences depending on the specific cellular context. Alternative splicing allows for the generation of many transcripts from a single gene, thereby expanding the proteome. Although all cells require the function of the spliceosome, neurons are highly sensitive to splicing perturbations with numerous neurological diseases linked to splicing defects. The sensitivity of neurons to splicing alterations is largely due to the complex neuronal cell types and functions in the nervous system that require specific splice isoforms to maintain cellular homeostasis. In the past several years, the relationship between RNA splicing and the nervous system has been the source of significant investigation. Here, we review the current knowledge on RNA splicing in neurobiology and discuss its potential role and impact in neurodegenerative diseases. We will examine the impact of alternative splicing and the role of splicing regulatory proteins on neurodegeneration, highlighting novel animal models including mouse and zebrafish. We will also examine emerging technologies and therapeutic interventions that aim to “drug” the spliceosome. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Processing > Splicing Regulation/Alternative Splicing RNA in Disease and Development > RNA in Development.

Original languageEnglish (US)
Article numbere1532
JournalWiley Interdisciplinary Reviews: RNA
DOIs
StatePublished - Jan 1 2019

Fingerprint

Alternative Splicing
RNA
Spliceosomes
RNA Splicing
Introns
Nervous System
Neurology
Protein Splicing
Neurons
Neurobiology
RNA Precursors
Zebrafish
Proteome
Neurodegenerative Diseases
Neurodegenerative diseases
Protein Isoforms
Cytoplasm
Homeostasis
Animal Models
Technology

Keywords

  • neurodegeneration
  • R-loops
  • splicing
  • therapuetics

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Splicing and neurodegeneration : Insights and mechanisms. / Nik, Sara; Bowman, Teresa V.

In: Wiley Interdisciplinary Reviews: RNA, 01.01.2019.

Research output: Contribution to journalReview article

@article{d8c84d3cad384f00b2ca0967179c49e6,
title = "Splicing and neurodegeneration: Insights and mechanisms",
abstract = "Splicing is the global cellular process whereby intervening sequences (introns) in precursor messenger RNA (pre-mRNA) are removed and expressed regions (exons) are ligated together, resulting in a mature mRNA transcript that is exported and translated in the cytoplasm. The tightly regulated splicing cycle is also flexible allowing for the inclusion or exclusion of some sequences depending on the specific cellular context. Alternative splicing allows for the generation of many transcripts from a single gene, thereby expanding the proteome. Although all cells require the function of the spliceosome, neurons are highly sensitive to splicing perturbations with numerous neurological diseases linked to splicing defects. The sensitivity of neurons to splicing alterations is largely due to the complex neuronal cell types and functions in the nervous system that require specific splice isoforms to maintain cellular homeostasis. In the past several years, the relationship between RNA splicing and the nervous system has been the source of significant investigation. Here, we review the current knowledge on RNA splicing in neurobiology and discuss its potential role and impact in neurodegenerative diseases. We will examine the impact of alternative splicing and the role of splicing regulatory proteins on neurodegeneration, highlighting novel animal models including mouse and zebrafish. We will also examine emerging technologies and therapeutic interventions that aim to “drug” the spliceosome. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Processing > Splicing Regulation/Alternative Splicing RNA in Disease and Development > RNA in Development.",
keywords = "neurodegeneration, R-loops, splicing, therapuetics",
author = "Sara Nik and Bowman, {Teresa V.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/wrna.1532",
language = "English (US)",
journal = "Wiley interdisciplinary reviews. RNA",
issn = "1757-7004",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Splicing and neurodegeneration

T2 - Insights and mechanisms

AU - Nik, Sara

AU - Bowman, Teresa V.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Splicing is the global cellular process whereby intervening sequences (introns) in precursor messenger RNA (pre-mRNA) are removed and expressed regions (exons) are ligated together, resulting in a mature mRNA transcript that is exported and translated in the cytoplasm. The tightly regulated splicing cycle is also flexible allowing for the inclusion or exclusion of some sequences depending on the specific cellular context. Alternative splicing allows for the generation of many transcripts from a single gene, thereby expanding the proteome. Although all cells require the function of the spliceosome, neurons are highly sensitive to splicing perturbations with numerous neurological diseases linked to splicing defects. The sensitivity of neurons to splicing alterations is largely due to the complex neuronal cell types and functions in the nervous system that require specific splice isoforms to maintain cellular homeostasis. In the past several years, the relationship between RNA splicing and the nervous system has been the source of significant investigation. Here, we review the current knowledge on RNA splicing in neurobiology and discuss its potential role and impact in neurodegenerative diseases. We will examine the impact of alternative splicing and the role of splicing regulatory proteins on neurodegeneration, highlighting novel animal models including mouse and zebrafish. We will also examine emerging technologies and therapeutic interventions that aim to “drug” the spliceosome. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Processing > Splicing Regulation/Alternative Splicing RNA in Disease and Development > RNA in Development.

AB - Splicing is the global cellular process whereby intervening sequences (introns) in precursor messenger RNA (pre-mRNA) are removed and expressed regions (exons) are ligated together, resulting in a mature mRNA transcript that is exported and translated in the cytoplasm. The tightly regulated splicing cycle is also flexible allowing for the inclusion or exclusion of some sequences depending on the specific cellular context. Alternative splicing allows for the generation of many transcripts from a single gene, thereby expanding the proteome. Although all cells require the function of the spliceosome, neurons are highly sensitive to splicing perturbations with numerous neurological diseases linked to splicing defects. The sensitivity of neurons to splicing alterations is largely due to the complex neuronal cell types and functions in the nervous system that require specific splice isoforms to maintain cellular homeostasis. In the past several years, the relationship between RNA splicing and the nervous system has been the source of significant investigation. Here, we review the current knowledge on RNA splicing in neurobiology and discuss its potential role and impact in neurodegenerative diseases. We will examine the impact of alternative splicing and the role of splicing regulatory proteins on neurodegeneration, highlighting novel animal models including mouse and zebrafish. We will also examine emerging technologies and therapeutic interventions that aim to “drug” the spliceosome. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Processing > Splicing Regulation/Alternative Splicing RNA in Disease and Development > RNA in Development.

KW - neurodegeneration

KW - R-loops

KW - splicing

KW - therapuetics

UR - http://www.scopus.com/inward/record.url?scp=85063156852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063156852&partnerID=8YFLogxK

U2 - 10.1002/wrna.1532

DO - 10.1002/wrna.1532

M3 - Review article

JO - Wiley interdisciplinary reviews. RNA

JF - Wiley interdisciplinary reviews. RNA

SN - 1757-7004

M1 - e1532

ER -